These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30156318)

  • 41. Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey.
    Shen H; Shahzad G; Jawairia M; Bostick RM; Mustacchia P
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1066-73. PubMed ID: 25176122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply.
    Buzzetti E; Tsochatzis EA
    Aliment Pharmacol Ther; 2019 Aug; 50(3):339. PubMed ID: 31313369
    [No Abstract]   [Full Text] [Related]  

  • 43. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low Utility of Noninvasive Fibrosis Scores in Young Adults with Nonalcoholic Fatty Liver Disease.
    Doycheva I; Shaker M; Allende D; Lopez R; Watt KD; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):652-653. PubMed ID: 28381858
    [No Abstract]   [Full Text] [Related]  

  • 46. Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010.
    Moon SW; Kim SY; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Ro JS; Lee YH; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2603-2611. PubMed ID: 30214178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study.
    Munsterman ID; Smits MM; Andriessen R; van Nieuwkerk CMJ; Bloemena E; Mulder CJJ; Tjwa ETTL; van Geenen EJM
    Scand J Gastroenterol; 2017 Aug; 52(8):881-885. PubMed ID: 28446050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Tasneem AA; Luck NH; Majid Z
    Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
    Yim JY; Kim J; Kim D; Ahmed A
    Liver Int; 2018 Nov; 38(11):2051-2059. PubMed ID: 29517842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease.
    Jeong WK
    Gut Liver; 2017 Sep; 11(5):577-578. PubMed ID: 28874039
    [No Abstract]   [Full Text] [Related]  

  • 51. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
    Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
    Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease.
    Oni ET; Sinha P; Karim A; Martin SS; Blaha MJ; Agatston AS; Blumenthal RS; Meneghelo RS; Conceiçao RD; Santos RD; Nasir K
    Arch Med Res; 2014 Jan; 45(1):52-7. PubMed ID: 24333254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough.
    Castera L
    Liver Int; 2018 Feb; 38 Suppl 1():67-70. PubMed ID: 29427494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
    Alkhouri N; Feldstein AE
    Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.
    Patel V; Sanyal AJ; Sterling R
    Clin Liver Dis; 2016 May; 20(2):277-92. PubMed ID: 27063269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R
    Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography.
    Lu YP; Wei J; Xu LR; Tang YY; Yuan Y; Zhang Y; Li YY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):921-928. PubMed ID: 25480592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
    Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
    Environ Health; 2018 Jan; 17(1):6. PubMed ID: 29334960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.